Posted by Michael Wonder on 08 Sep 2020

Singapore's Agency for Care Effectiveness publishes another tranche of drug guidances

ACE

1 September 2020 - Plain English summaries are also available.

Summaries are available for the following medicines:

  • Adalimumab - inflammatory conditions
  • Anti-retroviral agents - HIV infection
  • Benralizumab, mepolizumab & omalizumab - asthma
  • Blinatumomab - acute lymphoblastic leukaemia
  • Imatinib mesylate - chronic myeloid leukaemia and acute lymphoblastic leukaemia
  • Mycophenolate mofetil - immunosuppression
  • Trastuzumab - breast cancer and gastric cancer

Read ACE Plain English summaries


Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Health technology assessment , Publication , Singapore